Deutsch
Español
India
Italiano
Français
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Research
Benzinga Pro
Log In
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
Deutsch
Español
India
Italiano
Français
Sign in
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Options
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Options
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
DBV Technologies
(NASDAQ:DBVT)
Intraday
$0.66
-0.022
[-3.23%]
15 minutes delayed
Get Report
Watch
Perks
Buy
Compare Brokers
$0.66
-0.022
[-3.23%]
Last update: 5:47PM
Get Real Time Here
Get Report
Watch
Overview
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest News for DBV Technologies Stock (NASDAQ:DBVT)
DBV Technologies Stock (NASDAQ: DBVT)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Monday, March 18, 2024
12 Health Care Stocks Moving In Monday's Pre-Market Session
Benzinga Insights
-
Mar 18, 2024, 9:05AM
Thursday, March 07, 2024
DBV Technologies Q4 2023 GAAP EPS $(0.060), Sales $8.875M Beat $412.000K Estimate
Benzinga Newsdesk
-
Mar 7, 2024, 5:31PM
Earnings Scheduled For March 7, 2024
Benzinga Insights
-
Mar 7, 2024, 4:49AM
Wednesday, March 06, 2024
A Preview Of DBV Technologies's Earnings
Benzinga Insights
-
Mar 6, 2024, 12:01PM
Wednesday, February 21, 2024
HC Wainwright & Co. Reiterates Buy on DBV Technologies, Maintains $10 Price Target
Benzinga Newsdesk
-
Feb 21, 2024, 6:47AM
Tuesday, February 20, 2024
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Benzinga Insights
-
Feb 20, 2024, 8:05AM
Friday, February 09, 2024
DBV Technologies And 2 Other Stocks Under $2 Insiders Are Buying
Avi Kapoor
-
Feb 9, 2024, 6:02AM
Friday, December 01, 2023
Top 5 Health Care Stocks That Could Blast Off In December
Lisa Levin
-
Dec 1, 2023, 10:47AM
Wednesday, November 22, 2023
Chief Executive Officer at DBV Technologies Acquires Company Stock Options Worth 806,672 Shares
Benzinga Insights
-
Nov 22, 2023, 10:00AM
Monday, November 13, 2023
HC Wainwright & Co. Reiterates Buy on DBV Technologies, Maintains $10 Price Target
Benzinga Newsdesk
-
Nov 13, 2023, 11:01AM
Thursday, November 09, 2023
DBV Technologies Announces 2-Year Results From Ongoing Phase 3 Open-Label Extension To The EPITOPE Trial Of Viaskin Peanut In Toddlers
Benzinga Newsdesk
-
Nov 9, 2023, 6:46PM
Thursday, November 02, 2023
Goldman Sachs Maintains Sell on DBV Technologies, Lowers Price Target to $1
Benzinga Newsdesk
-
Nov 2, 2023, 9:57AM
Wednesday, November 01, 2023
Why Plus Therapeutics Shares Are Trading Higher By Over 11%; Here Are 20 Stocks Moving Premarket
Lisa Levin
-
Nov 1, 2023, 8:07AM
Monday, October 16, 2023
DBV Technologies Taps Pierre Fabre's Virginie Boucinha as CFO, Effective November 6 As Sébastien Robitaille Departs to Purse Other Opportunities
Benzinga Newsdesk
-
Oct 16, 2023, 3:19AM
Tuesday, August 29, 2023
Stereotaxis And 3 Other Stocks Under $2 Insiders Are Aggressively Buying
Lisa Levin
-
Aug 29, 2023, 9:21AM
Tuesday, August 15, 2023
DBV Technologies Chief Executive Officer Awarded $1.22M Worth of Stock Options
Benzinga Insights
-
Aug 15, 2023, 11:02AM
Friday, August 04, 2023
DBV Technologies And 3 Other Penny Stocks Insiders Are Buying
Lisa Levin
-
Aug 4, 2023, 3:56AM
Wednesday, August 02, 2023
Why Exact Sciences Shares Are Trading Lower By Over 9%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Lisa Levin
-
Aug 2, 2023, 1:07PM
Cambium Networks, SolarEdge Technologies, trivago And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
Lisa Levin
-
Aug 2, 2023, 6:26AM
Tuesday, August 01, 2023
JMP Securities Reiterates Market Outperform on DBV Technologies, Maintains $4 Price Target
Benzinga Newsdesk
-
Aug 1, 2023, 9:43AM
DBV Technologies Advances Peanut Allergy Program With FDA Support On Pediatric Studies
Vandana Singh
-
Aug 1, 2023, 9:29AM
HC Wainwright & Co. Reiterates Buy on DBV Technologies, Maintains $10 Price Target
Benzinga Newsdesk
-
Aug 1, 2023, 6:07AM
DBV Technologies Q2 EPS $(0.26) Up From $(0.35) YoY, Sales $2.30M Up From $1.53M YoY
Benzinga Newsdesk
-
Aug 1, 2023, 4:23AM
Monday, July 31, 2023
DBV Technologies Receives FDA Feedback On Design Elements For Viaskin Peanut Safety Studies; Expects To Seek Final Alignment With FDA On COMFORT Protocols Prior To Commencing Studies
Benzinga Newsdesk
-
Jul 31, 2023, 4:27PM
Wednesday, May 17, 2023
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Benzinga Insights
-
May 17, 2023, 9:06AM
Monday, May 15, 2023
Why Venus Concept Shares Are Trading Lower By Over 15%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Lisa Levin
-
May 15, 2023, 1:45PM
Sarepta Therapeutics, C3.ai, monday.com, And Other Big Stocks Moving Higher On Monday
Lisa Levin
-
May 15, 2023, 10:27AM
Thursday, May 11, 2023
Good News For Toddlers With Peanut Allergy: DBVT Data Shows Promising Results for Peanut Allergy Patch
Vandana Singh
-
May 11, 2023, 11:01AM
JMP Securities Reiterates Market Outperform on DBV Technologies, Maintains $4 Price Target
Benzinga Newsdesk
-
May 11, 2023, 7:56AM
Wednesday, May 10, 2023
DBV Technologies Says EPITOPE Phase 3 Data Published In The New England Journal Of Medicine, Highlighting Exciting Results For Toddlers With Peanut Allergy
Benzinga Newsdesk
-
May 10, 2023, 5:33PM
Tuesday, May 09, 2023
HC Wainwright & Co. Reiterates Buy on DBV Technologies, Maintains $10 Price Target
Benzinga Newsdesk
-
May 9, 2023, 6:37AM
Friday, May 05, 2023
JMP Securities Maintains Market Outperform on DBV Technologies, Maintains $4 Price Target
Benzinga Newsdesk
-
May 5, 2023, 8:48AM
Thursday, May 04, 2023
DBV Technologies Q1 EPS $(0.22) Misses $(0.21) Estimate, Sales $2.20M Beat $1.20M Estimate
Happy Mohamed
-
May 4, 2023, 5:14PM
Thursday, April 27, 2023
JMP Securities Reiterates Market Outperform on DBV Technologies, Maintains $4 Price Target
Benzinga Newsdesk
-
Apr 27, 2023, 7:53AM
Thursday, April 20, 2023
DBV Technologies Outlines Regulatory Path For Viaskin Peanut Allergy Patch For Kids Below 3 Years
Vandana Singh
-
Apr 20, 2023, 12:26PM
The FDA Confirmed That DBV Technologies' Phase 3 EPITOPE Study For Viaskin Peanut 250 μg Patch Met The Pre-specified Criteria For Success For The Primary Endpoint And Did Not Request An Additional Efficacy Study
Benzinga Newsdesk
-
Apr 20, 2023, 3:54AM
Wednesday, March 08, 2023
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Benzinga Insights
-
Mar 8, 2023, 8:06AM
JMP Securities Reiterates Market Outperform on DBV Technologies, Maintains $4 Price Target
Benzinga Newsdesk
-
Mar 8, 2023, 7:18AM
Friday, March 03, 2023
JMP Securities Reiterates Market Outperform on DBV Technologies, Maintains $4 Price Target
Benzinga Newsdesk
-
Mar 3, 2023, 8:48AM
HC Wainwright & Co. Reiterates Buy on DBV Technologies, Maintains $10 Price Target
Benzinga Newsdesk
-
Mar 3, 2023, 6:09AM
Thursday, March 02, 2023
DBV Technologies FY22 EPS $(1.24), Sales $4.8M
Michael Horton
-
Mar 2, 2023, 4:34PM
Earnings Scheduled For March 2, 2023
Benzinga Insights
-
Mar 2, 2023, 4:37AM
Wednesday, March 01, 2023
Earnings Preview: DBV Technologies
Benzinga Insights
-
Mar 1, 2023, 2:02PM
Monday, December 26, 2022
12 Health Care Stocks Moving In Monday's Intraday Session
Benzinga Insights
-
Dec 26, 2022, 12:32PM
12 Health Care Stocks Moving In Monday's Pre-Market Session
Benzinga Insights
-
Dec 26, 2022, 8:07AM
Friday, December 23, 2022
Dow Rises 150 Points; Mission Produce Shares Slide
Lisa Levin
-
Dec 23, 2022, 2:35PM
Why Applied Molecular Transport Shares Are Trading Lower By Over 55%? Here Are 47 Stocks Moving In Friday's Mid-Day Session
Lisa Levin
-
Dec 23, 2022, 1:24PM
12 Health Care Stocks Moving In Friday's Intraday Session
Benzinga Insights
-
Dec 23, 2022, 12:31PM
Dow Surges Over 100 Points; Crude Oil Rises Sharply
Lisa Levin
-
Dec 23, 2022, 12:15PM
DBV Technologies shares are trading higher after the company announced the FDA has lifted the partial clinical hold on its VITESSE Phase 3 Pivotal Trial.
Benzinga Newsdesk
-
Dec 23, 2022, 8:46AM
Show more
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch